{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T02:52:27Z","timestamp":1752461547941},"reference-count":0,"publisher":"National Library of Serbia","issue":"1-2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med pregl","MED PREGLED"],"published-print":{"date-parts":[[2012]]},"abstract":"<jats:p>Introduction. Application of blood and blood components throughout decades is\n   very successful and mostly safe procedure in patients? therapy. However, it\n   may lead to unfavourable effects, such as transfusion reactions. Material and\n   Methods. In the period from 2000 to 2009, 180 transfusion reactions were\n   reported at the Department of Clinical Transfusion of the Service for Blood\n   Transfusion of Vojvodina in Novi Sad. The aetiology of transfusion reactions\n   was determined by examining pretransfusion and post-transfusion sample of\n   patient?s blood and by examining the unit of blood component that induced\n   reaction. Results. Out of 180 reported transfusion reactions, 98 (54.4%) were\n   febrile non-haemolytic transfusion reactions, 69 (38.3%) allergic reactions\n   and 2 (1.11%) haemolytic reactions. Blood components that caused most of\n   transfusion reactions were erythrocytes (62.4%), fresh frozen plasma (11.2%)\n   and platelets (14.4%). All patients underwent multiple transfusions.\n   Discussion. The fact that only 0.13% transfusion reactions were reported,\n   compared with data from literature (2-15%), points to the lack of regular\n   reporting of transfusion reactions, as well as the fact that there is only\n   one report of delayed transfusion reaction. Conclusions. To improve and make\n   blood transfusion safer it is necessary to respect all pre-transfusion\n   procedures, constant follow up of blood transfusion must be done and patients\n   with diagnosed non-haemolytic transfusion reaction should be given leukocyte\n   reduced blood components.<\/jats:p>","DOI":"10.2298\/mpns1202050g","type":"journal-article","created":{"date-parts":[[2012,3,19]],"date-time":"2012-03-19T10:29:01Z","timestamp":1332152941000},"page":"50-53","source":"Crossref","is-referenced-by-count":5,"title":["Importance of haemovigilance and reports on transfusion reaction in blood component therapy"],"prefix":"10.2298","volume":"65","author":[{"given":"Jasmina","family":"Grujic","sequence":"first","affiliation":[{"name":"Zavod za transfuziju krvi Vojvodine, Novi Sad"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zdravko","family":"Gulan","sequence":"additional","affiliation":[{"name":"Zavod za transfuziju krvi Vojvodine, Novi Sad"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zorana","family":"Budakov","sequence":"additional","affiliation":[{"name":"Zavod za transfuziju krvi Vojvodine, Novi Sad"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1078","container-title":["Medicinski pregled","Medical review"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T09:23:11Z","timestamp":1685352191000},"score":1,"resource":{"primary":{"URL":"https:\/\/doiserbia.nb.rs\/Article.aspx?ID=0025-81051202050G"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":0,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.2298\/mpns1202050g","relation":{},"ISSN":["0025-8105","1820-7383"],"issn-type":[{"value":"0025-8105","type":"print"},{"value":"1820-7383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]}}}